Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lionel Trueb

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|June 28, 2024
Reflections on the opportunities and challenges of applying experience-based co-design (EBCD) to phase 1 clinical trials in oncologyNils Graber, Nina Canova, Denise Bryant-Lukosius, et al.
International Journal for Equity in Health|December 10, 2015
Characterizing the vulnerability of frequent emergency department users by applying a conceptual framework: a controlled, cross-sectional studyPatrick Bodenmann, Stéphanie Baggio, Katia Iglesias, et al.
Journal for Immunotherapy of Cancer|August 28, 2020
Guillain-Barré syndrome after adoptive cell therapy with tumor-infiltrating lymphocytesAngela Orcurto, Andreas Hottinger, Benita Wolf, et al.
Frontiers in Immunology|April 17, 2026
Case Report: Transverse myelitis following CAR-T cell therapy for post-transplant lymphoproliferative disorderNicolas Desbaillets, Ana Isabel Martín-Quesada, Arthur Mulvey, et al.
Cytotherapy|October 18, 2020
Development of an optimized closed and semi-automatic protocol for Good Manufacturing Practice manufacturing of tumor-infiltrating lymphocytes in a hospital environmentPhilippe O Gannon, Alexandre Harari, Aymeric Auger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2026
Combinatorial delivery of low-dose radiotherapy and immunotherapy to patients with immune-excluded tumors enhances CD8+ T cell functionalityMaria Ochoa-de-Olza, Nicolas Rayroux, Martina Imbimbo, et al.
Immunity|September 14, 2024
Tumor-reactive T cell clonotype dynamics underlying clinical response to TIL therapy in melanomaJohanna Chiffelle, David Barras, Rémy Pétremand, et al.
Science Immunology|February 2, 2024
Response to tumor-infiltrating lymphocyte adoptive therapy is associated with preexisting CD8<sup>+</sup> T-myeloid cell networks in melanomaDavid Barras, Eleonora Ghisoni, Johanna Chiffelle, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|June 28, 2024
Reflections on the opportunities and challenges of applying experience-based co-design (EBCD) to phase 1 clinical trials in oncologyNils Graber, Nina Canova, Denise Bryant-Lukosius, et al.
International Journal for Equity in Health|December 10, 2015
Characterizing the vulnerability of frequent emergency department users by applying a conceptual framework: a controlled, cross-sectional studyPatrick Bodenmann, Stéphanie Baggio, Katia Iglesias, et al.
Journal for Immunotherapy of Cancer|August 28, 2020
Guillain-Barré syndrome after adoptive cell therapy with tumor-infiltrating lymphocytesAngela Orcurto, Andreas Hottinger, Benita Wolf, et al.
Frontiers in Immunology|April 17, 2026
Case Report: Transverse myelitis following CAR-T cell therapy for post-transplant lymphoproliferative disorderNicolas Desbaillets, Ana Isabel Martín-Quesada, Arthur Mulvey, et al.
Cytotherapy|October 18, 2020
Development of an optimized closed and semi-automatic protocol for Good Manufacturing Practice manufacturing of tumor-infiltrating lymphocytes in a hospital environmentPhilippe O Gannon, Alexandre Harari, Aymeric Auger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2026
Combinatorial delivery of low-dose radiotherapy and immunotherapy to patients with immune-excluded tumors enhances CD8+ T cell functionalityMaria Ochoa-de-Olza, Nicolas Rayroux, Martina Imbimbo, et al.
Immunity|September 14, 2024
Tumor-reactive T cell clonotype dynamics underlying clinical response to TIL therapy in melanomaJohanna Chiffelle, David Barras, Rémy Pétremand, et al.
Science Immunology|February 2, 2024
Response to tumor-infiltrating lymphocyte adoptive therapy is associated with preexisting CD8<sup>+</sup> T-myeloid cell networks in melanomaDavid Barras, Eleonora Ghisoni, Johanna Chiffelle, et al.
Pageof 3